Some studies showed that the quantity of SARS-CoV-2–specific T-cells was not proportional to disease severity (8, 10, 23), or that the impaired virus-specific T-cells response is detected in CD4+ lymphocytes of severe patients in the acute phase of infection, but not in CD8+ lymphocytes (11). This evidence concerns the gene CD4 and infection.